Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 509-511

  Rocha, Monica S ^a,b   Teerlink, Tom ^a   Janssen, Mirian C H ^c   Kluijtmans, Leo A J ^c   Smulders, Yvo ^a   Jakobs, Cornelis ^a   Tavares de Almeida, Isabel ^b   Rivera, Isabel ^b   Castro, Rita ^b   Blom, Henk J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ADMA; Cystathionine synthase deficiency; Hyperhomocysteinemia

Indexed keywords

6 N,N' DIMETHYLARGININE; ARGININE; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CORRELATIONAL STUDY; CYSTATHIONINE BETA SYNTHASE DEFICIENCY; ENZYME DEFICIENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL;

ADULT; ARGININE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS;

EID: 84861343777     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.03.009     Document Type: Article

References (19)

1. Castro R., Rivera I., Blom H.J., Jakobs C., Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 2006, 29:3-20.
2. Stühlinger M.C., Stanger O. Asymmetric dimethyl-l-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. Curr Drug Metab 2005, 6:3-14.
3. Teerlink T. Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance. Clin Chem Lab Med 2005, 43:1130-1138.
4. Dayal S., Rodionov R.N., Arning E., et al. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 2008, 295:H816-H825.
5. Esse R., Rocha M.S., Barroso M., et al. S-Adenosyl homocysteine accumulation decreases global protein arginine methylation status in cultured human endothelial cells. J Inherit Metab Dis 2010, 33(Suppl.):1S-35S.
6. Wilcken D.E., Wang J., Sim A.S., Green K., Wilcken B. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function. J Inherit Metab Dis 2006, 29:30-37.
7. Kanzelmeyer N, Tsikas D, Chobanyan-Jurgens K, et al. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria. Amino Acids 2011, in press. doi:10.1007/s00726-011-0892-4.
8. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987, 422:43-52.
9. Teerlink T., Nijveldt R.J., de Jong S., van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002, 303:131-137.
10. Bode-Böger S.M., Scalera F., Ignarro L.J. The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther 2007, 114:295-306.
11. Kielstein J.T., Salpeter S.R., Bode-Böger S.M., Cooke J.P., Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a meta-analysis. Nephrol Dial Transplant 2006, 21:2446-2451.
12. Jonasson T.F., Hedner T., Hultberg B., Ohlin H. Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease. Eur J Clin Invest 2003, 33:543-549.
13. Lücke T., Kanzelmeyer N., Kemper M.J., Tsikas D., Das A.M. Developmental changes in the l-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age. Clin Chem Lab Med 2007, 45:1525-1530.
14. Holven K.B., Haugstad T.S., Holm T., Aukrust P., Ose L., Nenseter M.S. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects. Br J Nutr 2003, 89:359-363.
15. Spoelstra-de Man A.M., Teerlink T., Brouwer C.B., Rauwerda J.A., Stehouwer C.D., Smulders Y.M. No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk. Clin Endocrinol (Oxf) 2006, 64:495-501.
16. Heil S.G., Riksen N.P., Boers G.H., Smulders Y.M., Blom H.J. DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients. Mol Genet Metab 2007, 91:55-60.
17. Doshi S., McDowell I., Goodfellow J., et al. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia. Metabolism 2005, 54:351-360.
18. Tousoulis D., Bouras G., Antoniades C., et al. Methionine-induced homocysteinemia impairs endothelial function in hypertensives: the role of asymmetrical dimethylarginine and antioxidant vitamins. Am J Hypertens 2011, 24:936-942.
19. Cardounel A.J., Zweier J.L. Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury. J Biol Chem 2002, 277:33995-34002.